Bifidobacterium pseudocatenulatum
Bifidobacterium pseudocatenulatum is a gram-positive anaerobic bacterium commonly found in the human gut microbiota and studied extensively in probiotic research. In vitro and animal studies have characterized its enzyme production (β-glucosidase, β-galactosidase, phytase), metabolic capabilities with dietary compounds (isoflavones, ellagic acid, flavonoids), synbiotic optimization with prebiotics, and its role in cholesterol metabolism, diet-induced obesity, and inflammation-related conditions studied via bile acid metabolism and the gut-bone and gut-joint axes. Research has examined multiple strains with varying functional properties. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 232 body-system-tagged papers that concern each system. Research coverage, not measured effect.
+4 more systems
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 55 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
+11 more symptoms
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
425 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
PMID 39742294 →Gut Bifidobacterium pseudocatenulatum protects against fat deposition by enhancing secondary bile acid biosynthesis· iMeta · 2024
-
[2]
PMID 39315793 →Selective human milk oligosaccharide utilization by members of the Bifidobacterium pseudocatenulatum taxon· Applied and Environmental Microbiology · 2024
-
[3]
Source →Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer· bioRxiv (Cold Spring Harbor Laboratory) · 2024
-
[4]
PMID 30251018 →Bifidobacterium pseudocatenulatum CECT 7765 supplementation improves inflammatory status in insulin-resistant obese children· European Journal of Nutrition · 2018
-
[5]
PMID 18685499 →Quantification of Folic Acid in Human Feces After Administration of Bifidobacterium Probiotic Strains· Journal of Clinical Gastroenterology · 2008